Drugs / CLNP-BPO2.5
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01016977 Comparator | Oct 2009 → Apr 2010 | acne | Stiefel, a GSK Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CLNP-BPO2.5 | “clindamycin phosphate 1.2%-benzoyl peroxide 2.5% (CLNP-BPO2.5)” PMID 23513559 ↗ Feb 2013 |
| Route | Topical | “when applied topically once daily for 12 weeks” PMID 23513559 ↗ Feb 2013 |